Literature DB >> 25398438

Intracellular Osteopontin inhibits toll-like receptor signaling and impedes liver carcinogenesis.

Xiaoyu Fan1, Chunyan He2, Wei Jing3, Xuyu Zhou3, Rui Chen1, Lei Cao2, Minhui Zhu3, Rongjie Jia1, Hao Wang1, Yajun Guo4, Jian Zhao4.   

Abstract

Osteopontin (OPN) has been implicated widely in tumor growth and metastasis, but the range of its contributions is not yet fully understood. In this study, we show that genetic ablation of Opn in mice sensitizes them to diethylnitrosamine (DEN)-induced hepatocarcinogenesis. Opn-deficient mice (Opn(-/-) mice) exhibited enhanced production of proinflammatory cytokines and compensatory proliferation. Administering OPN antibody or recombinant OPN protein to wild-type or Opn(-/-) mice-derived macrophages, respectively, had little effect on cytokine production. In contrast, overexpression of intracellular OPN (iOPN) in Opn-deficient macrophages strongly suppressed production of proinflammatory cytokines. In addition, we found that iOPN was able to interact with the pivotal Toll-like receptor (TLR) signaling protein MyD88 in macrophages after stimulation with cellular debris, thereby disrupting TLR signaling in macrophages. Our results indicated that iOPN was capable of functioning as an endogenous negative regulator of TLR-mediated immune responses, acting to ameliorate production of proinflammatory cytokines and curtail DEN-induced hepatocarcinogenesis. Together, our results expand the important role of OPN in inflammation-associated cancers and deepen its relevance for novel treatment strategies in liver cancer. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398438     DOI: 10.1158/0008-5472.CAN-14-0615

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Serum osteopontin is a predictor of prognosis for HBV-associated acute-on-chronic liver failure.

Authors:  Longgen Liu; Jianchun Lu; Chunyan Ye; Lin Lin; Shuqin Zheng; Hongyu Zhang; Qing Lan; Yuan Xue
Journal:  Biomed Rep       Date:  2017-12-13

2.  Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment.

Authors:  Frank Szulzewsky; Nina Schwendinger; Dilansu Güneykaya; Patrick J Cimino; Dolores Hambardzumyan; Michael Synowitz; Eric C Holland; Helmut Kettenmann
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

Review 3.  Danger signals in liver injury and restoration of homeostasis.

Authors:  Hui Han; Romain Desert; Sukanta Das; Zhuolun Song; Dipti Athavale; Xiaodong Ge; Natalia Nieto
Journal:  J Hepatol       Date:  2020-05-01       Impact factor: 25.083

4.  Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma.

Authors:  Kai-Qian Zhou; Wei-Feng Liu; Liu-Xiao Yang; Yun-Fan Sun; Jie Hu; Fei-Yu Chen; Cheng Zhou; Xiang-Yu Zhang; Yuan-Fei Peng; Lei Yu; Jian Zhou; Jia Fan; Zheng Wang
Journal:  Hepatobiliary Surg Nutr       Date:  2019-12       Impact factor: 7.293

5.  Lack of galectin-1 exacerbates chronic hepatitis, liver fibrosis, and carcinogenesis in murine hepatocellular carcinoma model.

Authors:  Tamara Potikha; Orit Pappo; Lina Mizrahi; Devorah Olam; Sebastián M Maller; Gabriel A Rabinovich; Eithan Galun; Daniel S Goldenberg
Journal:  FASEB J       Date:  2019-03-21       Impact factor: 5.834

6.  Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.

Authors:  Matteo Tardelli; Karina Zeyda; Veronica Moreno-Viedma; Bettina Wanko; Nicole G Grün; Günther Staffler; Maximilian Zeyda; Thomas M Stulnig
Journal:  Mol Metab       Date:  2016-09-13       Impact factor: 7.422

Review 7.  Is Osteopontin a Friend or Foe of Cell Apoptosis in Inflammatory Gastrointestinal and Liver Diseases?

Authors:  Tomoya Iida; Kohei Wagatsuma; Daisuke Hirayama; Hiroshi Nakase
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

8.  Suppression of osteopontin inhibits chemically induced hepatic carcinogenesis by induction of apoptosis in mice.

Authors:  Su-Hyung Lee; Jun-Won Park; Sang-Ho Woo; Du-Min Go; Hyo-Jung Kwon; Ja-June Jang; Dae-Yong Kim
Journal:  Oncotarget       Date:  2016-12-27

Review 9.  Role of Osteopontin in Liver Diseases.

Authors:  Yankai Wen; Seogsong Jeong; Qiang Xia; Xiaoni Kong
Journal:  Int J Biol Sci       Date:  2016-08-06       Impact factor: 6.580

Review 10.  Osteopontin at the Crossroads of Inflammation and Tumor Progression.

Authors:  Luigi Mario Castello; Davide Raineri; Livia Salmi; Nausicaa Clemente; Rosanna Vaschetto; Marco Quaglia; Massimiliano Garzaro; Sergio Gentilli; Paolo Navalesi; Vincenzo Cantaluppi; Umberto Dianzani; Anna Aspesi; Annalisa Chiocchetti
Journal:  Mediators Inflamm       Date:  2017-07-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.